We believe all patients should get the medications they need at a cost they can afford.
Across America, AMCP monitors and advocates for a range of health care issues and policies. Our mission is to improve medication access, elevate patient health outcomes, and optimize health care spending through evidence-based medication strategies. You can make a difference.
Prescription Digital Therapeutics (PDTs Act)
Prescription digital therapeutics (PDTs) are software-based therapies shown to benefit those with mental health conditions like depression. However, many PDTs do not currently fit into one of the statutorily defined coverage categories for the Medicare or Medicaid programs, leaving beneficiaries of those programs—which include some of America’s most vulnerable populations—without access to these effective and accessible treatments.
Our Position: AMCP supports the Access to Prescription Digital Therapeutics Act, an important bipartisan bill that would help remedy this disparity by creating a comprehensive benefit category and expanding Medicare coverage to include PDTs.
How you can get involved:
Equitable Community Access to Pharmacist Services (ECAPS) Act
The Ensuring Community Access to Pharmacist Services (ECAPS) Act of 2025 (H.R. 3164) is an important bipartisan bill that will extend certain COVID-era provisions such as such as testing, vaccination, and common disease treatments that have been a critical lifeline for millions of patients.
Our Position: AMCP urges lawmakers to pass the ECAPS Act to help ensure patients across the country maintain reliable access to testing and treatment for COVID-19, respiratory syncytial virus (RSV), the flu, and potential future threats to public health.
How you can get involved:
Medicaid VBPs for Patients Act (MVP Act)
Value-based payments (VBP) systems incentivize providers to improve patient outcomes, reduce costs, and improve the overall patient experience, making them a critical tool for promoting high-quality, affordable care. However, defining and measuring the value of a drug can be complex, especially when considering factors like clinical outcomes, patient characteristics, and population health.
Our Position: AMCP supports the Medicaid VBPs for Patients (MVP) Act to modernize the framework for value-based purchasing arrangements in Medicaid, ensuring that the proper channels exist to connect Medicaid patients with the therapies they need.
How you can get involved:
Inflation Reduction Act (IRA) Implementation
Signed into law in 2022, the Inflation Reduction Act (IRA) ushered in Medicare prescription drug pricing reforms and imposed caps on out-of-pocket expenses for Part D beneficiaries. While much discussion and analysis has focused on how the IRA will impact Medicare beneficiaries, Part D plans, and government spending, the impact of the legislation will extend to stakeholders across the U.S. health care industry.
How you can get involved:
PBM Reform
Policymakers frequently target pharmacy benefit managers (PBMs) in a well-meaning attempt to contain rising drug prices, but some proposed changes could have the opposite effect for patients.
Our Position: AMCP encourages PBM reform efforts to focus on common-sense requirements for transparency reporting by PBMs. It’s time for a more nuanced discussion about PBM reform—one that lowers the temperature and puts patients first.
How you can get involved:
-
Advocacy Event Calendar
Get involved in the managed care community and meet other AMCP advocates at our next events.
-
Share Your Story
Share how public policies impact your daily work and guide AMCP policy development and shape future advocacy efforts.
-
Annual AAO Report
The latest on the value of managed care pharmacy and its impact on patients and the health care system.
